Initiate Hold/Resume – A resume time is now mandatory when the Hold function is utilized. This is a patient safety issue. RNs do not have access to the Hold/Resume function; they must DC the current order and enter a new order. (Enter Hold-Resume Information)
Order sets default to open – if desired, this can be changed in your preferences from the Desktop screen.
Echo after hours – The process is unchanged. Continue to page or call the on-call technician.
Patient’s Own Med – This may be entered as the medication name. Complete all fields to complete the order.
Option #1: Order the product. If order to give now, the transfusion indication screens will appear automatically for completion. The product may be ordered, but held or pending surgery. A transfusion order will be required to give the product. Blood bank does not release the product without the transfusion order/indications completed.
Option #2: Order transfusion of product being held (product already ordered)– Select Transfusion Order to access the order and indication screens.
Consent remains on paper to allow for patient/family signature.
Edit titration parameters - You may edit within Administration Criteria. To view the pre-populated parameters, be sure to select the string for titration.
qHS and qDay options – These are not approved abbreviations. Select Bedtime or Daily.
Meds vs. Fluids – It has been requested that plain IV fluids be listed under Medications also. At this time, we are unable to do this. Plain IV fluids are listed under Fluids; IV fluids with a medication are listed under Medications
Topical medications – application site no longer required
Changing med route (IV to PO, etc.) – The initial order must be DC’d and a new order placed for the new route.
Electrolyte order set – Pharmacy will automatically DC the order if the patient’s creatinine is >1.5 since that is the criteria for utilizing the order set.
“Pick a Med String” - Always select a string for medications, then edit. It will minimize the fields you have to complete before filing.